EAR
Eargo, Inc. Common Stock
Delisted
EAR was delisted on the 15th of February, 2024.
About: Eargo Inc is a medical device company, focused on improving the quality of life of people with hearing loss. The company offers hearing aids, professional support services, and other insurance-related services through a direct-to-consumer format with a personalized, consumer-centric approach. The product portfolio includes Eargo Neo HiFi, Eargo 5, Eargo 6, Eargo 7, and related accessories.
Employees: 243
Financial journalist opinion
Neutral
GlobeNewsWire
1 year ago
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings
Eargo will provide customers with even more over-the-counter (OTC) choices to help address hearing loss on their own terms Eargo will provide customers with even more over-the-counter (OTC) choices to help address hearing loss on their own terms
Neutral
Business Wire
1 year ago
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eargo, Inc. (NasdaqGS: EAR) to an affiliate of Patient Square Capital. Under the terms of the proposed transaction, shareholders of Eargo will receive $2.55 in cash for each share of Eargo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whet.
Neutral
PRNewsWire
1 year ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Eargo, Inc.
NEW YORK , Dec. 19, 2023 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Eargo, Inc. ("Eargo" or the "Company") (NASDAQ: EAR) stock prior to October 30 th, 2023 . You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Eargo, Inc. with an affiliate of Patient Square Capital (or "Patient Square").
Neutral
Accesswire
1 year ago
Wolf Popper LLP Investigates the Acquisition of Eargo, Inc. by Its Controlling Shareholder, Patient Square Capital
NEW YORK, NY / ACCESSWIRE / December 12, 2023 / Wolf Popper LLP is investigating claims on behalf of investors in Eargo, Inc. (NASDAQ:EAR) concerning the acquisition of Eargo by its controlling shareholder, Patient Square Capital. Under the terms of the acquisition, Eargo shareholders would receive $2.55 per share in cash.
Charts implemented using Lightweight Charts™